What Amble Health does

Amble Health Inc. is a privately held, direct-pay telehealth company headquartered in Cortland, Ohio, founded in 2023 to deliver weight-management and metabolic/anti-aging treatments to U.S. consumers without insurance involvement. The platform connects patients in all 50 states with licensed providers via an online medical intake questionnaire, issues prescriptions, and routes fulfillment through a partner pharmacy network — Bask Health, Inc. — connecting the platform to state-licensed 503A and FDA-registered 503B pharmacies that dispense both FDA-approved and compounded medications, which are then shipped directly to patients with free expedited delivery.

The core product surface is organized around two prescription tracks: a Weight Loss program centered on GLP-1 injections (semaglutide and tirzepatide) for adults meeting BMI-based clinical criteria, and an Anti-Aging program offering compounded injectables (NAD+, Sermorelin, Tesamorelin, Glutathione, Lipo-B, Lipo-C). The company also operates a separately positioned Medical Kits line of consumer emergency-prep kits, five free online health calculators driving organic acquisition, and the Amble Cares Program — a structurally subsidized tier launched in May 2026 offering eligible low-income Americans up to 50% lower GLP-1 pricing under a third-party-verified direct-pay model. Trustpilot displays 4.6 stars across 2,000+ reviews and the company claims 250,000+ patients.

Monetization is subscription-recurring, with plans starting at $99/month, GLP-1 injections from $179/month, and HSA/FSA accepted on 3-month-or-longer plans; non-refundable once dispensed. Growth channels combine organic content/calculator SEO, a $50/$50 referral program, Instagram testimonials, Trustpilot social proof, and BNPL rails (Affirm, Klarna, Afterpay). Amble operates as a managed services provider and is not itself a HIPAA-covered entity; it functions as a business associate to its partner pharmacies and providers. The company is subject to heightened regulatory scrutiny in the GLP-1 telehealth category, including a documented Tennessee hospitalization case tied to a near-9x semaglutide starting dose and an FDA adverse-event surge to over 25,000 reports in 2025.

Name

Amble Health

Legal name

Amble Health Inc.

Website

https://joinamble.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

Amble Health is a 100% online direct-pay telehealth platform serving patients in all 50 U.S. states with subscription-based weight-loss (GLP-1) and anti-aging injectable treatments, fulfilled through a partner pharmacy network and an Amble Cares subsidized tier for low-income Americans.

Ownership category

akta.pro rank

Product category

Telehealth Weight Management

NAICS

Offices of Physicians (6211)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription) (HLALAIAA)

akta.pro secondary industries

Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD), Chronic Condition Medication Programs (e.g., diabetes, hypertension) with Integrated Prescribing (HLALAIAH)

Keywords

• Telehealth weight loss
• GLP-1 medications
• Online medical consultations
• Anti-aging injections
• Direct-pay healthcare

Headquarters

HQ city

Cortland

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Subscription Membership Plans: Extended treatment memberships at discounted rates providing ongoing access to services, prescribed medications (if eligible), and continued healthcare provider support over the selected duration. Medications may be dispensed in one or three-month increments. Plans are non-refundable once medication has been dispensed.
2. Individual Product Sales: One-time or subscription-based purchases of specific treatments including GLP-1 injections, NAD+, Sermorelin, Glutathione, Lipo-B, and Lipo-C injections. Pricing varies by treatment type with transparent flat-rate pricing.
3. Amble Cares Program Revenue: Direct-pay model offering GLP-1 weight loss treatments at up to 50% reduced pricing for eligible low-income patients. Operates as a structural affordability solution rather than temporary subsidy. Participants pay out-of-pocket and cannot combine with insurance, FSA/HSA, Medicare, or Medicaid.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Amble Health operates a 100% online direct-pay telehealth platform connecting patients with licensed physicians across all 50 U.S. states for prescription-based injectable treatments. Its core offerings are GLP-1 weight loss injections (semaglutide and tirzepatide) for chronic weight management and a line of anti-aging/wellness injections (NAD+, Sermorelin, Tesamorelin, Glutathione, Lipo-B, Lipo-C). Patients complete an online medical intake, receive provider review and ongoing secure-messaging support, and have medications fulfilled and shipped to their door through a partner pharmacy network of state-licensed 503A and FDA-registered 503B pharmacies.

Product overview

Amble Health is a telehealth platform operating as a managed services provider connecting patients with licensed healthcare providers across all 50 U.S. states. The platform offers two primary service tracks: Weight Loss (centered on GLP-1 injections including semaglutide and tirzepatide) and Anti-Aging (featuring NAD+, Sermorelin, Tesamorelin, Glutathione, Lipo-B, and Lipo-C injections). The core offering is prescription-based injectable medications delivered through a partner pharmacy network, with medications shipped directly to patients. Supporting tools include BMI, TDEE, Calorie Deficit, Protein, and Water Intake calculators. A separate Medkits line provides emergency preparedness kits (Radiation, Mayday, Just in Case, Breathe Easy, Ouch Pouch, Cold Reaper, Viral Ick, and Panic Pack). The Amble Cares Program is a subsidized access initiative for low-income populations offering GLP-1 treatments at reduced pricing. The platform does not fill prescriptions directly or provide medical advice, instead facilitating telehealth consultations and prescription logistics through technology and administrative support.

Differentiator

Problem solved

Functional benefit

Brands

• Amble Cares Program: A structural program designed to expand access to GLP-1 weight loss treatments for low-income Americans, offering up to 50% lower cost through a direct-pay model.

Products and services

• GLP-1 Injections Semaglutide and tirzepatide injection treatments prescribed online for chronic weight management in adults with BMI of 30+ or BMI of 27+ with weight-related comorbidities, prescribed alongside reduced-calorie diet and increased physical activity and self-administered as weekly subcutaneous injections.
• NAD+ Injections Nicotinamide Adenine Dinucleotide (NAD+) compounded injection therapy for anti-aging, energy production, cellular repair, and metabolic function support, administered subcutaneously.
• Sermorelin Injections Growth hormone-releasing peptide injection for anti-aging and muscle growth support that stimulates the body's natural growth hormone production.
• Tesamorelin Injection Growth hormone-releasing hormone analog injection that naturally boosts growth hormone levels for anti-aging purposes.
• Glutathione Injections Antioxidant tripeptide injection for immune support, liver detoxification, and skin health, administered subcutaneously or intramuscularly, typically 200-800mg one to three times weekly.
• Lipo-B Injection Lipotropic B-complex injection containing cyanocobalamin, thiamine, riboflavin, niacinamide, pyridoxine, and dexpanthenol, supporting energy metabolism and red blood cell formation.
• Lipo-C Injection Lipotropic injection containing methionine, inositol, choline, and pyridoxine (B6), intended to support fat metabolism, energy production, and overall metabolic health.
• Amble Cares Program Subsidized access program providing GLP-1 weight loss treatments at up to 50% lower cost to eligible low-income Americans, with eligibility verified by a third-party financial verification partner.
• Radiation Emergency Kit Emergency preparedness medical kit designed for radiation exposure scenarios.
• Mayday Travel Emergency Kit Travel-focused emergency medical kit for on-the-go preparedness.
• Just in Case Kit General emergency preparedness kit packed and ready for unexpected situations.
• Breathe Easy Kit Mold and allergy-focused medical kit for respiratory support.
• Ouch Pouch Kit First aid kit with supplies beyond basic bandages.
• Cold Reaper Kit Cold and immunity-focused medical kit.
• Viral Ick Kit Defense kit against viral and microscopic threats.
• Panic Pack Kit Field emergency kit for critical situations.

Quantifiable outcome

• 88% of members dropped a clothing size or more
• +4 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• Third-Party Financial Verification PartnercoreTechnology or Integration · 1 May 2026An unnamed independent third-party verification partner determines patient eligibility for the Amble Cares Program based on verified financial need. This partner applies consistent eligibility criteria to all applicants, determining both eligibility and specific discount levels for the program.
• Bask Health, Inc.coreTechnology or IntegrationBask Health, Inc. (555 Madison Avenue, Suite 1202, New York NY 10022) serves as the primary pharmacy network provider for Amble's prescription fulfillment services. They connect patients with state-licensed 503A pharmacies and FDA-registered 503B outsourcing facilities within their pharmacy network to dispense both FDA-approved and compounded medications prescribed through the Amble platform.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Ro: Direct-to-consumer telehealth platform providing online consultations, prescriptions, and pharmacy fulfillment across weight management (including GLP-1s), men's and women's health. Closely matches Amble's model of physician-led online care with integrated pharmacy delivery.
• Sesame: Cash-pay marketplace for telehealth and in-person care across primary care, weight management, and specialty conditions. Comparable to Amble in cash-pay positioning and breadth of online consultations.
• Calibrate: DTC metabolic health platform combining telehealth prescribing (including GLP-1s) with coaching. Direct competitor in the chronic-condition weight management subscription category.
• Found: DTC weight management platform combining telehealth prescribing (including GLP-1s where appropriate) with behavior change support. Comparable to Amble's condition-specific Rx program for chronic weight management.
• Mochi Health: DTC telehealth provider specializing in weight management with online physician visits and prescription fulfillment, including compounded GLP-1s. Specifically named alongside Amble in KFF Health News reporting on telehealth semaglutide adverse events, making it a near-direct comparison.
• Hims & Hers Health: Public, scaled DTC telehealth platform offering cash-pay subscriptions across weight loss (including GLP-1s), sexual health, dermatology, and mental health. Directly comparable to Amble in business model, customer base, and cash-pay positioning, but with substantially greater scale and capital.

Broad incumbents

• Teladoc Health: Large incumbent telehealth provider offering general medical, mental health, and condition management services. Overlaps with Amble in online physician consultations and chronic-condition management, though more enterprise/payer-oriented than cash-pay DTC.
• Eli Lilly (LillyDirect): Lilly's direct-to-patient channel for its branded GLP-1s (Zepbound). As the manufacturer of tirzepatide, Lilly is both a supplier risk and a competitor to telehealth prescribers like Amble that rely on dispensing or co-prescribing these molecules.

Emerging players

• Noom (Noom Med): Behavior-change platform that added a GLP-1 prescribing arm (Noom Med). Competes with Amble by bundling telehealth prescribing with a well-known lifestyle/coaching brand in weight management.

Others

• Bask Health: Amble's core pharmacy network partner connecting patients with 503A and 503B pharmacies for compounded and branded GLP-1 fulfillment. Not a competitor but a critical infrastructure/enabler whose relationship directly affects Amble's supply and economics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/amble-health

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Amble Health